Chemo-immunotherapy outcomes of KRAS-G12C mutant lung cancer compared to other molecular subtypes of KRAS-mutant lung cancer.
暂无分享,去创建一个
M. Ladanyi | C. Rudin | M. Kris | M. Arcila | Gregory Riely | M. Hellmann | P. Lito | H. Rizvi | M. Awad | B. Ricciuti | K. Arbour | H. Yu